AIMD
Ainos, Inc. NASDAQ$1.71
Mkt Cap $7.3M
52w Low $1.26
13.9% of range
52w High $4.50
50d MA $1.58
200d MA $2.47
P/E (TTM)
-0.5x
EV/EBITDA
-1.9x
P/B
1.0x
Debt/Equity
1.4x
ROE
-195.3%
P/FCF
-1.5x
RSI (14)
—
ATR (14)
—
Beta
2.32
50d MA
$1.58
200d MA
$2.47
Avg Volume
72.9K
About
Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nu…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | AMC | — | -0.85 | — | 1.35 | -1.5% | +3.0% | +6.7% | +6.7% | +10.4% | +9.6% | — |
| Nov 13, 2025 | AMC | — | -0.64 | — | 2.58 | -3.1% | -14.3% | -14.3% | -13.6% | -21.7% | -26.0% | — |
| Aug 13, 2025 | AMC | — | -0.99 | — | 3.36 | +0.9% | +13.7% | +3.0% | -0.3% | -0.6% | +3.0% | — |
| May 12, 2025 | AMC | — | -1.05 | — | 2.75 | +1.8% | -1.8% | -3.6% | -1.1% | -1.1% | -4.0% | — |
| Mar 7, 2025 | AMC | — | -1.30 | — | 2.44 | -2.5% | -5.7% | -3.7% | -5.7% | -1.6% | +7.0% | — |
| Nov 6, 2024 | AMC | — | -1.65 | — | 2.53 | -9.1% | -5.5% | -5.1% | -1.2% | -1.6% | -2.8% | — |
| Aug 5, 2024 | AMC | — | -2.45 | — | 2.65 | -1.5% | -6.4% | -1.9% | -2.6% | -1.5% | +6.4% | — |
| May 13, 2024 | AMC | — | -2.85 | — | 5.30 | -0.9% | -1.9% | -2.8% | -1.9% | -1.9% | -5.7% | — |
| Mar 8, 2024 | AMC | — | -1.37 | — | 10.25 | -17.6% | -20.0% | -28.3% | -33.7% | -37.1% | -41.0% | — |
| Feb 7, 2024 | AMC | — | -0.73 | — | 4.70 | +1.1% | -3.0% | -2.6% | +0.9% | -4.3% | -2.1% | — |
Recent Filings
Data updated apr 24, 2026 4:51pm
· Source: massive.com